Sabrina A. Assoumou, MD MPH, is the inaugural Louis W. Sullivan, MD, Professor of Medicine and Assistant Professor of Medicine at Boston University School of Medicine. She is also an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for patients with human immunodeficiency virus (HIV) at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.
Dr. Assoumou has published in multiple journals including Clinical Infectious Diseases, AIDS, Annals of Internal Medicine and the Journal of American Medical Association. Her work has also been included in the American Association for the Study of Liver Diseases (AASLD)/ Infectious Diseases Society of America (IDSA) recommendations for testing, managing and treating HCV (Assoumou et al., Clin Infect Dis 2018) as well as HCV testing recommendations by the Centers for Disease Control and Prevention (Assoumou et al., Clin Infect Dis 2018 and Assoumou et al., Clin Infect Dis. 2019). Dr. Assoumou has also presented her findings at the National Academy of Sciences to the panel tasked with developing a National Strategy for the Elimination of Hepatitis B and C and at international scientific meetings such as IDWeek and the Conference on Retroviruses and Opportunistic Infections (CROI).
Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health. Dr. Assoumou received an Excellence in Teaching Hospital-Based Faculty Award at BMC in 2017. She was also recognized as the Distinguished Faculty of the Month in April 2020 for her service to the BUSM community in teaching, service on committees, mentoring of students, trainees and junior faculty. The same year she also received a Department of Medicine Evans Junior Faculty Research Merit Award recognizing an outstanding record of scholarship and research. Dr. Assoumou’s impact on the medical campus and beyond culminated in 2021 in her installation as the inaugural Louis W. Sullivan, MD, Professor of Medicine which honors Dr. Sullivan’s contributions to his alma mater – Boston University School of Medicine and to the medical field as former Health and Human Services Secretary and the first Dean of Morehouse Medical School.
Dr. Assoumou has also contributed to COVID 19-related efforts as part of the NIH-funded Massachusetts Community Engagement Alliance (MA-CEAL), and the Commonwealth of Massachusetts’ “Trust the Facts, Get the Vax” public awareness campaign. Further, she was appointed by Mayor Michelle Wu to the City of Boston’s COVID-19 Advisory Committee. She has also become a trusted source for local, national and international news outlets such as BBC Worldwide, ABC Australia, NBC News, Reuters, Bloomberg, Newsweek, TIME, PBS, The Boston Globe, The Bay State Banner, Boston 25 as well as local NPR affiliates WBUR and WGBH.
- Assistant Professor, Infectious Diseases, Medicine, Boston University School of Medicine
- University of Rochester School of Medicine & Dentistry, MD
- Harvard School of Public Health, MPH
- Williams College, BA
- Published on 3/21/2022
Savinkina A, Madushani RWMA, Eftekhari Yazdi G, Wang J, Barocas JA, Morgan JR, Assoumou SA, Walley AY, Linas BP, Murphy SM. Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis. Addiction. 2022 Mar 21. PMID: 35315162.
- Published on 2/2/2022
Massey ESG, Bazzi AR, Sian CR, Gebel CM, Bernstein JA, Assoumou SA. "I've been 95% safe": perspectives on HIV pre-exposure prophylaxis at a drug detoxification center: a qualitative study. AIDS Care. 2022 Feb 02; 1-5. PMID: 35109737.
- Published on 2/1/2022
Linas BP, Assoumou SA. Laying the Foundation for a New and Inclusive Science. JAMA Netw Open. 2022 02 01; 5(2):e2148540. PMID: 35157061.
- Published on 1/4/2022
Cole MB, Raifman JR, Assoumou SA, Kim JH. Assessment of Administration and Receipt of COVID-19 Vaccines by Race and Ethnicity in US Federally Qualified Health Centers. JAMA Netw Open. 2022 01 04; 5(1):e2142698. PMID: 35006248.
- Published on 11/1/2021
Harvey L, Taylor JL, Assoumou SA, Kehoe J, Schechter-Perkins EM, Bernstein E, Walley AY. Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic. J Addict Med. 2021 Nov-Dec 01; 15(6):461-467. PMID: 34734572.
- Published on 5/21/2021
Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764. PMID: 34051547.
- Published on 4/27/2021
Burns RH, Pierre CM, Marathe JG, Ruiz-Mercado G, Taylor JL, Kimmel SD, Johnson SL, Fukuda HD, Assoumou SA. Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. Open Forum Infect Dis. 2021 Aug; 8(8):ofab208. PMID: 34409120.
- Published on 3/30/2021
Berger Z, Altiery DE Jesus V, Assoumou SA, Greenhalgh T. Long COVID and Health Inequities: The Role of Primary Care. Milbank Q. 2021 06; 99(2):519-541. PMID: 33783907.
- Published on 3/22/2021
Assoumou SA, Paniagua SM, Gonzalez P, Wang J, Beckwith CG, White LF, Taylor JL, Coogan K, Samet JH, Linas BP. HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges. AIDS Behav. 2021 Aug; 25(8):2591-2598. PMID: 33751315.
- Published on 2/24/2021
Sinha P, Jafarzadeh SR, Assoumou SA, Bielick CG, Carpenter B, Garg S, Harleen S, Neogi T, Nishio MJ, Sagar M, Sharp V, Kissin EY. The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study. J Infect Dis. 2021 02 24; 223(4):581-588. PMID: 33216906.
View 21 more publications: View full profile at BUMC